Aperta Biosciences, LLC

SAINT LOUIS, MO · Founded 2017 · CIK 0001758162 · Biotech · Private

Therapeutic molecules for treating blepharitis and ocular surface disease

apertabio.com →
Grants
—
No SBIR or STTR on record
Sector median: 1
Raised
$175K
1 Form D · Nov 2018
95 months since last filing
Contracts
—
No federal contracts on record
Patents
5
2 granted · 3 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Private capital raisedForm D · SEC$175,000
Form D · SEC

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1481Eyevance Pharmaceuticals——
1482PROTHERA BIOLOGICS, INC.—$250K
1483Modulate Bio Inc.—$200K
1484Aperta Biosciences, LLC—$175K
1485Treovir, Inc.—$133K
1486APTINYX, INC.—$95M
1487Selva Nexus, Inc.—$50K

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Forrest CoxDirector · Executive Officer · Promoter
  • Jonathan FeldmannDirector · Executive Officer · Promoter
  • Frameshift, LLC Frameshift, LLCDirector · Promoter
  • Carlos SantosDirector · Executive Officer · Promoter

Patents

USPTO · 2 granted of 5

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.